GeneNews Ltd (TSE:GEN – Get Free Report) was up 7.1% during mid-day trading on Monday . The stock traded as high as C$0.15 and last traded at C$0.15. Approximately 473,147 shares changed hands during mid-day trading, a decline of 68% from the average daily volume of 1,480,179 shares. The stock had previously closed at C$0.14.
GeneNews Stock Performance
The firm has a 50 day moving average price of C$0.15. The company has a market capitalization of C$25.49 million and a price-to-earnings ratio of -2.21.
About GeneNews
GeneNews Limited focuses on developing and commercializing proprietary molecular diagnostic tests for the early detection of diseases and personalized health management with a primary focus on cancer-related indications. Its proprietary platform technology, the Sentinel Principle, identifies novel biomarkers from whole blood.
Recommended Stories
- Five stocks we like better than GeneNews
- How to Calculate Stock Profit
- 3 CEO-Led Turnaround Stocks You Can Still Buy
- What is an Earnings Surprise?
- 3 Value Stocks You Can Buy Before They Become Big
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- Chinese Stocks Stage Impressive Rebound
Receive News & Ratings for GeneNews Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GeneNews and related companies with MarketBeat.com's FREE daily email newsletter.